Kothari Fermentation & Biochem Ltd.

As of June 30, 2026, Kothari Fermentation & Biochem Ltd. carries a market capitalization of 670.95M, placing it among publicly traded companies globally. Its enterprise value stands at 670.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Kothari Fermentation & Biochem Ltd. has 15.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Kothari Fermentation & Biochem Ltd. trades at an EV/EBITDA multiple of 8.95 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 133.68 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 670.95M versus a market cap of 670.95M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 5.77M in revenue per employee across its workforce of 206.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Kothari Fermentation & Biochem Ltd. recorded an income tax benefit of -4.24M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -25.42M and -21.18M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Kothari Fermentation & Biochem Ltd.'s stock has declined approximately 18.95% over the past 52 weeks. The 50-day moving average sits at 42.01, while the 200-day moving average is 41.84.

Over the twelve months ended June 30, 2026, Kothari Fermentation & Biochem Ltd. generated 1.19B in revenue and converted that into -21.18M in net income, yielding earnings per share of -1.38. EBITDA reached 74.96M, while operating income came in at 5.02M.

Over the twelve months ended June 30, 2026, Kothari Fermentation & Biochem Ltd. posted a gross margin of 51.54, reflecting its pricing power and cost economics. The operating margin of 0.42 and net profit margin of -1.78 provide insight into operational efficiency.